J.P. Mehta

Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial

Steven D. Nathan, Victor F. Tapson, Jean Elwing et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 72 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

Paul Cremer, Antonio Abbate, Kristin Hudock et al. · The Lancet Rheumatology · 2021 · 69 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension

Leslie Spikes, Abubakr Bajwa, Charles D. Burger et al. · Pulmonary Circulation · 2022 · 38 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Granulomatous‐lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency

Basheer Tashtoush, Roya Memarpour, Jose Ramirez et al. · The Clinical Respiratory Journal · 2016 · 31 citations

Life Sciences, Immunology, Pathology +16

Generation of Oxidants by Hypoxic Human Pulmonary and Coronary Smooth-Muscle Cells

J.P. Mehta, Jian Campian, Juan Guardiola et al. · CHEST Journal · 2008 · 30 citations

Life Sciences, Cardiology, Physiology +14